Status:
ACTIVE_NOT_RECRUITING
Robotic vs. Conventional Minimal-invasive Inguinal Hernia Repair
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Clarunis - Universitäres Bauchzentrum Basel
St. Claraspital AG
Conditions:
Hernia, Inguinal
Robotic Surgical Procedures
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Minimal invasive techniques have become a well established approach for inguinal hernia repair over the last decade in developed countries. Different techniques such as total extraperitoneal endoscopi...
Eligibility Criteria
Inclusion
- Patients older than 18 years of age and able to understand and give their informed consent for the study.
- Primary unilateral or bilateral hernia
Exclusion
- Recurrent hernia
- with previous open abdominal surgery at or below the umbilicus
- need of an open inguinal hernia repair (patient's preference, unable to undergo general anesthesia, unable to tolerate pneumoperitoneum)
- liver disease defined by the presence of ascites
- end-stage renal disease requiring dialysis
- unable to give informed consent
- need of an emergency surgery
- pregnancy
Key Trial Info
Start Date :
January 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT05216276
Start Date
January 17 2022
End Date
December 31 2025
Last Update
January 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clarunis AG
Basel, Basel-Landschaft, Switzerland, 4002